Linda is Sr. Director of Regulatory Policy & Intelligence at Sanofi and has held RA positions at Bayer and Block Drug/GSK, with global regulatory responsibilities for submissions, life cycle management and due diligence. She is a RAPS Fellow, RAC for US/CDN/EU, and is on the RAPS Board.
PRESENTER
(S):
Steven Bass, Bass Biopharm Consulting Group LLC, United States
Dr Bass is a Pharmaceutical Labeling consultant & also serves as Vice President, Talent Acquisition for Ruderfer & Associates and executive Biopharmaceutical Search Firm. He currently is chair of the Labeling Working Group of the DIA Regulatory Affairs SIAC.
Brooke has more than 10 years Regulatory experience as a strategist and publishing expert in global markets. She is the Chairperson of the DIA Regulatory Intelligence SIAC and active member in various organizations to promote Regulatory awareness.
Description
During this showcase, leaders from the labeling and regulatory intelligence working groups will discuss hot and emerging topics in regulatory affairs. Learn about current trends in industry, how companies are handling the ever changing regulatory environment, and share approaches your organization may be leveraging. Developed by the Regulatory Affairs (RA) SIAC.
Learning Objectives: Define best practices in identifying, analyzing, interpreting and integrating changes to the regulatory environment Compare approaches in handling these changes.